日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL-SHC1信号轴介导HER2异常肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药

Ishida, Masaki; Yamada, Tadaaki; Katayama, Yuki; Kawachi, Hayato; Sawada, Ryo; Nakamura, Ryota; Hirai, Soichi; Matsui, Yohei; Morimoto, Kenji; Onoi, Keisuke; Nakamura-Sasada, Aosa; Horinaka, Mano; Sakai, Toshiyuki; Sakakida, Tomoki; Doi, Toshifumi; Yasumoto, Kazuo; Goto, Yasuhiro; Furuya, Naoki; Taniguchi, Hirokazu; Ogino, Hirokazu; Takayuki, Nakano; Chihara, Yusuke; Fukuda, Koji; Taniguchi, Hiroaki; Uehara, Hisanori; Yano, Seiji; Tokuda, Shinsaku; Takayama, Koichi

Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database

利用综合临床试验数据库分析脆弱性对局部晚期非小细胞肺癌患者同步放化疗疗效的影响

Morimoto, Kenji; Yamada, Tadaaki; Nishioka, Naoya; Yamamoto, Nobuyuki; Niho, Seiji; Okamoto, Isamu; Hotta, Katsuyuki; Okamoto, Hiroaki; Sugawara, Shunichi; Shimokawa, Toshio; Ozawa, Yuichi; Oizumi, Satoshi; Takayama, Koichi

Dual-Readout Self-Resetting CMOS Image Sensor for Resolving Sub-Percent Optical Contrast in Biomedical Imaging

用于生物医学成像中亚百分比光学对比度分辨的双读出自复位CMOS图像传感器

Sasagawa, Kiyotaka; Iwaki, Subaru; Morimoto, Kenji; Okada, Ryoma; Takehara, Hironari; Haruta, Makito; Tashiro, Hiroyuki; Ohta, Jun

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy

癌症恶病质对PD-L1肿瘤比例评分≥50%的非小细胞肺癌患者接受帕博利珠单抗单药治疗与免疫检查点抑制剂联合化疗治疗预后的临床影响

Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi

Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer

突变蛋白表达对EGFR L858R突变型非小细胞肺癌患者临床结局的影响

Nakamura, Ryota; Yamada, Tadaaki; Morimoto, Kenji; Yoshimura, Akihiro; Shiotsu, Shinsuke; Motono, Nozomu; Uramoto, Hidetaka; Imabayashi, Tatsuya; Takemura, Yoshizumi; Katayama, Yuki; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Okada, Satoru; Shimomura, Masanori; Inoue, Masayoshi; Tanaka, Noriyuki; Miyagawa-Hayashino, Aya; Takayama, Koichi

Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan

免疫相关不良事件对PD-L1低表达晚期非小细胞肺癌患者临床结局的影响,以肺炎为重点:一项日本多中心回顾性研究

Goda, Shiho; Yamada, Tadaaki; Morimoto, Kenji; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Hibino, Makoto; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi

Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50

临床因素对老年非小细胞肺癌患者(PD-L1 TPS ≥ 50)接受免疫检查点抑制剂联合或不联合化疗的预后影响

Takei, Shota; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi

Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study

揭示TTF-1表达对PD-L1高表达非鳞状非小细胞肺癌免疫治疗疗效的影响:一项回顾性多中心研究

Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.

联合靶向 AXL 和 ATR 对胸膜间皮瘤细胞的影响

Hirai Soichi, Yamada Tadaaki, Katayama Yuki, Ishida Masaki, Kawachi Hayato, Matsui Yohei, Nakamura Ryota, Morimoto Kenji, Horinaka Mano, Sakai Toshiyuki, Sekido Yoshitaka, Tokuda Shinsaku, Takayama Koichi

Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer

来自全国范围内的综合基因组分析检测非小细胞肺癌驱动癌基因的数据

Ishida, Masaki; Iwasaku, Masahiro; Doi, Toshifumi; Ishikawa, Takeshi; Tachibana, Yusuke; Sawada, Ryo; Ogura, Yuri; Kawachi, Hayato; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Tokuda, Shinsaku; Yamada, Tadaaki; Takayama, Koichi